Der skal tages passende, aseptiske forholdsregler i overensstemmelse med retningslinier for God farmaceutisk Fremstillingspraksis for at opretholde serilitet i YTRACIS og for at opretholde sterilitet under hele mærkningsproceduren.
Appropriate aseptic precautions should be taken, complying with the requirements of Good Pharmaceutical Manufacturing Practice, in order to maintain the sterility of YTRACIS and to maintain sterility throughout the labelling procedures.